RIP antibody
| Antigen |
|
| Clonality |
Polyclonal |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
Alternatives Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP), Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
|
| Catalog no. |
ABIN127073 |
| Quantity |
0.1 mg (0.5 mg/ml) (Variants) |
| Price |
319.00 $ Plus shipping costs $45.00
|
|
|
| Shipping to |
|
| Availability |
Will be delivered in 6 to 8 Business Days |
|
Alternative name
|
|
|
UniProt
|
Q13546
|
|
Immunogen
|
Synthetic peptide surrounding amino acid 645 of Human RIP
|
|
Cross-Reactivity
|
Human, Mouse (Murine), Rat (Rattus)
|
|
Description
|
RIP (Receptor Interacting Protein) is a 74 kDa Ser/Thr kinase which interacts with CD95(Fas/Apo1) receptor and the tumor necrosis factor receptor (TNFR1). It is a cell deathdomain adapter protein which can bind to the adapter proteins TRADD, RAID, and TRAF2. RIP contains an N-terminal region with homology to protein kinase, an intermediatedomain capable of association with MAPKKK and a C-terminal region containing anintracellular death domain motif. RIP activates both p38 MAP kinase and SAPK families. Invitro, RIP induces apoptosis, as well as SAPK/JNK and NF-kB activation. RIP possesseskinase activity as it autophosphorylates itself on serine and threonine residues.
|
|
Characteristics
|
Synonyms: RIPK1, Receptor-interacting serine/threonine-protein kinase 1, Serine/threonine-proteinkinase RIP, Cell death protein RIP, Receptor-Interacting Protein
|
|
Application Notes
|
Western Blot: 2-6 µg/ml. Immunoprecipitation. Immunohistochemistry. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
|
|
Concentration
|
0.5 mg/ml
|
|
Purification
|
Affinity Purified
|
|
Buffer
|
PBS, pH 7.2, containing 30% Glycerol, 0.5% BSA as stabilizer and 0.01%Thimerosal as preservative.
|
|
Storage
|
Store the antibody undiluted at -20°C or (in aliquots) at -70°C for long term storage. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
|
|
Research Area
|
Cancer, Apoptosis/Necrosis
|
|
Restrictions
|
For Research Use only
|
|
|
Stanger, Leder, Lee et al.: "RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death." in: Cell, Vol. 81, Issue 4, pp. 513-23, 1995 (PubMed).
Hsu, Huang, Shu et al.: "TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex." in: Immunity, Vol. 4, Issue 4, pp. 387-96, 1996 (PubMed).
|
Alternatives for antigen "RIP", type "Antibodies"
|
Hosts
|
Rabbit (6), Mouse (5)
|
|
Reactivities
|
Human (10), Mouse (Murine) (4), Rat (Rattus) (2)
|
|
Applications
|
Western Blotting (WB) (10), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (5), ELISA (4), Immunohistochemistry (IHC) (1)
|
|
Epitopes
|
AA 133-422 (5), C-Term (1), Internal Region,AA 286-314 (1), N-Term (1), N-Term,AA 151-180 (1)
|